Share this article

print logo

University at Buffalo awards biomedical and bioengineering grants to 16 companies

More than $500,000 has been awarded to 16 life-sciences companies from a University at Buffalo center that helps scientific innovations reach the commercial marketplace.

UB’s Center for Advanced Biomedical and Bioengineering Technology, or CAT, is part of the university’s New York State Center of Excellence in Bioinformatics and Life Sciences and is one of 15 such centers located around the state. It is one of three centers focused on the biomedical sector.

The 16 companies receiving awards for 2016-17 include several notable life-sciences firms and startups, including: Abcombi Biosciences, which boosts access to vaccines and allows the vaccines to work more efficiently; Albany Molecular Research Inc., which has moved into a drug-discovery hub on the Buffalo Niagara Medical Campus; and ONY Inc., the maker of Infasurf, a drug given to premature infants to help them breathe.

The program is sponsored by the state Division of Science, Technology and Innovation, or NYSTAR.

Also, Jeff Dunbar, director for UB’s Office of Science, Technology Transfer and Economic Outreach, known as STOR, has been named co-director of UB’s CAT with Norma Nowak, executive director of the bioinformatics center, who has served as CAT’s director and principal investigator since 2014.

There are no comments - be the first to comment